208 related articles for article (PubMed ID: 35701874)
1. Mitochondrial H
Li Z; Xia H; Sharp TE; LaPenna KB; Elrod JW; Casin KM; Liu K; Calvert JW; Chau VQ; Salloum FN; Xu S; Xian M; Nagahara N; Goodchild TT; Lefer DJ
Circ Res; 2022 Jul; 131(3):222-235. PubMed ID: 35701874
[TBL] [Abstract][Full Text] [Related]
2. Impaired branched chain amino acid oxidation contributes to cardiac insulin resistance in heart failure.
Uddin GM; Zhang L; Shah S; Fukushima A; Wagg CS; Gopal K; Al Batran R; Pherwani S; Ho KL; Boisvenue J; Karwi QG; Altamimi T; Wishart DS; Dyck JRB; Ussher JR; Oudit GY; Lopaschuk GD
Cardiovasc Diabetol; 2019 Jul; 18(1):86. PubMed ID: 31277657
[TBL] [Abstract][Full Text] [Related]
3. Hydrogen sulfide attenuates cardiac dysfunction after heart failure via induction of angiogenesis.
Polhemus D; Kondo K; Bhushan S; Bir SC; Kevil CG; Murohara T; Lefer DJ; Calvert JW
Circ Heart Fail; 2013 Sep; 6(5):1077-86. PubMed ID: 23811964
[TBL] [Abstract][Full Text] [Related]
4. 3-Mercaptopyruvate sulfurtransferase/hydrogen sulfide protects cerebral endothelial cells against oxygen-glucose deprivation/reoxygenation-induced injury via mitoprotection and inhibition of the RhoA/ROCK pathway.
Zhang F; Chen S; Wen JY; Chen ZW
Am J Physiol Cell Physiol; 2020 Oct; 319(4):C720-C733. PubMed ID: 32813542
[TBL] [Abstract][Full Text] [Related]
5. Defective branched chain amino acid catabolism contributes to cardiac dysfunction and remodeling following myocardial infarction.
Wang W; Zhang F; Xia Y; Zhao S; Yan W; Wang H; Lee Y; Li C; Zhang L; Lian K; Gao E; Cheng H; Tao L
Am J Physiol Heart Circ Physiol; 2016 Nov; 311(5):H1160-H1169. PubMed ID: 27542406
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular phenotype of mice lacking 3-mercaptopyruvate sulfurtransferase.
Peleli M; Bibli SI; Li Z; Chatzianastasiou A; Varela A; Katsouda A; Zukunft S; Bucci M; Vellecco V; Davos CH; Nagahara N; Cirino G; Fleming I; Lefer DJ; Papapetropoulos A
Biochem Pharmacol; 2020 Jun; 176():113833. PubMed ID: 32027885
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Effect of Targeting Branched-Chain Amino Acid Catabolic Flux in Pressure-Overload Induced Heart Failure.
Chen M; Gao C; Yu J; Ren S; Wang M; Wynn RM; Chuang DT; Wang Y; Sun H
J Am Heart Assoc; 2019 Jun; 8(11):e011625. PubMed ID: 31433721
[TBL] [Abstract][Full Text] [Related]
8. Induction of heart failure by minimally invasive aortic constriction in mice: reduced peroxisome proliferator-activated receptor γ coactivator levels and mitochondrial dysfunction.
Faerber G; Barreto-Perreia F; Schoepe M; Gilsbach R; Schrepper A; Schwarzer M; Mohr FW; Hein L; Doenst T
J Thorac Cardiovasc Surg; 2011 Feb; 141(2):492-500, 500.e1. PubMed ID: 20447656
[TBL] [Abstract][Full Text] [Related]
9. H₂S protects against pressure overload-induced heart failure via upregulation of endothelial nitric oxide synthase.
Kondo K; Bhushan S; King AL; Prabhu SD; Hamid T; Koenig S; Murohara T; Predmore BL; Gojon G; Gojon G; Wang R; Karusula N; Nicholson CK; Calvert JW; Lefer DJ
Circulation; 2013 Mar; 127(10):1116-27. PubMed ID: 23393010
[TBL] [Abstract][Full Text] [Related]
10. Hydrogen sulfide regulates cardiac mitochondrial biogenesis via the activation of AMPK.
Shimizu Y; Polavarapu R; Eskla KL; Nicholson CK; Koczor CA; Wang R; Lewis W; Shiva S; Lefer DJ; Calvert JW
J Mol Cell Cardiol; 2018 Mar; 116():29-40. PubMed ID: 29408195
[TBL] [Abstract][Full Text] [Related]
11. Hydrogen Sulfide Modulates Endothelial-Mesenchymal Transition in Heart Failure.
Li Z; Xia H; Sharp TE; LaPenna KB; Katsouda A; Elrod JW; Pfeilschifter J; Beck KF; Xu S; Xian M; Goodchild TT; Papapetropoulos A; Lefer DJ
Circ Res; 2023 Jan; 132(2):154-166. PubMed ID: 36575984
[TBL] [Abstract][Full Text] [Related]
12. Exercise Enhances Branched-Chain Amino Acid Catabolism and Decreases Cardiac Vulnerability to Myocardial Ischemic Injury.
Wu G; Guo Y; Li M; Li C; Tan Y; Li Y; Li J; Wang L; Zhang X; Gao F
Cells; 2022 May; 11(10):. PubMed ID: 35626742
[TBL] [Abstract][Full Text] [Related]
13. Mercaptopyruvate acts as endogenous vasodilator independently of 3-mercaptopyruvate sulfurtransferase activity.
Mitidieri E; Tramontano T; Gurgone D; Citi V; Calderone V; Brancaleone V; Katsouda A; Nagahara N; Papapetropoulos A; Cirino G; d'Emmanuele di Villa Bianca R; Sorrentino R
Nitric Oxide; 2018 May; 75():53-59. PubMed ID: 29452248
[TBL] [Abstract][Full Text] [Related]
14. Nitrite Therapy Ameliorates Myocardial Dysfunction via H2S and Nuclear Factor-Erythroid 2-Related Factor 2 (Nrf2)-Dependent Signaling in Chronic Heart Failure.
Donnarumma E; Bhushan S; Bradley JM; Otsuka H; Donnelly EL; Lefer DJ; Islam KN
J Am Heart Assoc; 2016 Jul; 5(8):. PubMed ID: 27473036
[TBL] [Abstract][Full Text] [Related]
15. PGC-1β deficiency accelerates the transition to heart failure in pressure overload hypertrophy.
Riehle C; Wende AR; Zaha VG; Pires KM; Wayment B; Olsen C; Bugger H; Buchanan J; Wang X; Moreira AB; Doenst T; Medina-Gomez G; Litwin SE; Lelliott CJ; Vidal-Puig A; Abel ED
Circ Res; 2011 Sep; 109(7):783-93. PubMed ID: 21799152
[TBL] [Abstract][Full Text] [Related]
16. Sodium Sulfide Attenuates Ischemic-Induced Heart Failure by Enhancing Proteasomal Function in an Nrf2-Dependent Manner.
Shimizu Y; Nicholson CK; Lambert JP; Barr LA; Kuek N; Herszenhaut D; Tan L; Murohara T; Hansen JM; Husain A; Naqvi N; Calvert JW
Circ Heart Fail; 2016 Apr; 9(4):e002368. PubMed ID: 27056879
[TBL] [Abstract][Full Text] [Related]
17. Protection conferred by myocardial ATP-sensitive K+ channels in pressure overload-induced congestive heart failure revealed in KCNJ11 Kir6.2-null mutant.
Yamada S; Kane GC; Behfar A; Liu XK; Dyer RB; Faustino RS; Miki T; Seino S; Terzic A
J Physiol; 2006 Dec; 577(Pt 3):1053-65. PubMed ID: 17038430
[TBL] [Abstract][Full Text] [Related]
18. The protective role of the 3-mercaptopyruvate sulfurtransferase (3-MST)-hydrogen sulfide (H
Nasi S; Ehirchiou D; Chatzianastasiou A; Nagahara N; Papapetropoulos A; Bertrand J; Cirino G; So A; Busso N
Arthritis Res Ther; 2020 Mar; 22(1):49. PubMed ID: 32183900
[TBL] [Abstract][Full Text] [Related]
19. Potential role of the 3-mercaptopyruvate sulfurtransferase (3-MST)-hydrogen sulfide (H
Augsburger F; Szabo C
Pharmacol Res; 2020 Apr; 154():104083. PubMed ID: 30500457
[TBL] [Abstract][Full Text] [Related]
20. Regulation of Vascular Tone, Angiogenesis and Cellular Bioenergetics by the 3-Mercaptopyruvate Sulfurtransferase/H2S Pathway: Functional Impairment by Hyperglycemia and Restoration by DL-α-Lipoic Acid.
Coletta C; Módis K; Szczesny B; Brunyánszki A; Oláh G; Rios EC; Yanagi K; Ahmad A; Papapetropoulos A; Szabo C
Mol Med; 2015 Feb; 21(1):1-14. PubMed ID: 25715337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
